Further, cell surface expression of TLR3 has been reported in a variety of cells such as pulmonary cells, hepatocytes, breast cancer, prostate cancer, and epithelial adenocarcinoma (4–6) indicating that its signaling occurs through the plasma membrane. Here, TLR3 is linked to prostate cancer.